Pediatric infectious diseases (PID) physicians prevent and treat childhood infections through clinical care, research, public health, education, antimicrobial stewardship, and infection prevention. This article is part of an American Board of Pediatrics Foundation–sponsored supplement investigating the future of the pediatric subspecialty workforce. The article offers context to findings from a modeling analysis estimating the supply of PID subspecialists in the United States between 2020 and 2040. It provides an overview of children cared for by PID subspecialists, reviews the current state of the PID workforce, and discusses the projected headcount and clinical workforce equivalents of PID subspecialists at the national, census region, and census division levels over this 2-decade period. The article concludes by discussing the education and training, clinical practice, policy, and research implications of the data presented. Adjusting for population growth, the PID workforce is projected to grow more slowly than most other pediatric subspecialties and geographic disparities in access to PID care are expected to worsen. In models considering alternative scenarios, decreases in the number of fellows and time spent in clinical care significantly affect the PID workforce. Notably, model assumptions may not adequately account for potential threats to the PID workforce, including a declining number of fellows entering training and the unknown impact of the COVID-19 pandemic and future emerging infections on workforce attrition. Changes to education and training, clinical care, and policy are needed to ensure the PID workforce can meet the future needs of US children.

The pediatric infectious diseases (PID) subspecialty includes physicians who devote their careers to clinical care, research, public health, advocacy, and medical education. Additionally, PID physicians lead activities that are legally or functionally required for health system operations, including antimicrobial stewardship, laboratory oversight, and infection prevention. PID subspecialists contribute broadly to community health through leadership in public health departments, vaccine education, and coordination of responses to infectious disease outbreaks or epidemics. These additional roles extend the demand on the PID workforce and, although critical to the functioning of our health system, impact the time for direct patient care. In this article, part of a supplement focused on the pediatric subspecialty workforce, we provide context to findings from a modeling analysis estimating the supply of PID subspecialists in the United States between 2020 and 2040.1  In discussing these results, we describe characteristics of the current PID workforce, highlight anticipated changes in the future demand for PID subspecialty care, and suggest multiple approaches to ensure the strength of the PID workforce over the coming decades.

Infectious diseases remain a significant cause of morbidity and mortality among infants, children, adolescents, and young adults (hereafter, “children”) in the United States. Infections account for ∼25% of all pediatric hospitalizations, with respiratory infections, urinary tract infections, and sepsis being among the most prevalent and costly inpatient conditions.25  PID subspecialists identify, treat, and prevent existing, reemerging, and novel infectious diseases that affect children in hospital and community settings. PID subspecialists also play key roles in multidisciplinary teams caring for children with impaired immunity, medical complexity, critical illness, and antibiotic-resistant infections.

More than half of children admitted to US hospitals receive antibiotics.6  Antimicrobial stewardship programs are required for hospitals to receive accreditation and federal funding; there is increasing evidence that these programs reduce medical expenditures.79  Diagnostic stewardship, including new diagnostic tests such as molecular pathogen panels, aims to optimize the use of laboratory testing and can have synergistic benefits when paired with antimicrobial stewardship.10,11  Finally, the complexity of antimicrobial resistance mechanisms and slow development of new antibiotics require expertise in childhood antibiotic-resistant infections.9,12 

Although the advent of antibiotics and vaccines heralded hope for eradicating infectious diseases, global changes have countered these advances. In particular, the threat of emerging and reemerging pathogens escalates as the global population grows, global connectivity increases, and climate change expands the range of locations suitable to pathogens, vectors, or reservoir species.1315  The past decade has seen the emergence of the Middle East Respiratory Syndrome coronavirus in 2012, the Ebola virus epidemic in 2013-2016, the Zika virus epidemic in 2015, and the global COVID-19 pandemic in 2019, all of which resulted in substantial pediatric morbidity and mortality. We anticipate that these demographic and climate shifts will drive the emergence of new infectious diseases and that expertise will be needed to understand, diagnose, prevent, and treat these infections.16 

Survival of children with inherited and acquired immunodeficiencies has improved substantially over the past several decades, resulting in rapid growth in the number of immunocompromised children.1722  These children are vulnerable to infections caused by routine, opportunistic, or multidrug-resistant pathogens associated with high morbidity and mortality.2224  Many health systems have developed consultation services dedicated to preventing and treating infections in these vulnerable children. Several institutions have also developed 1-year, nonaccredited sub-subspecialty fellowship programs following a 3-year PID fellowship that provides additional training in pediatric immunocompromised host infectious diseases. Expansion of these training opportunities will be needed to care for this growing population of immunocompromised children.

Over the centuries, much childhood morbidity and mortality have resulted from infectious diseases, particularly diarrheal and respiratory illnesses. The establishment of major pediatric organizations, including the American Pediatric Society (1888), the American Academy of Pediatrics (1930), the Society for Pediatric Research (1931), and the American Board of Pediatrics (1933), fostered a strong clinical, public health, and research focus on pediatric infectious diseases.25  PID became an American Board of Pediatrics (ABP) certified subspecialty in 1994.

Based on ABP data through June 2023, 1876 physicians have ever been board-certified in PID, of which 1368 (72.9%) were actively enrolled in Maintenance of Certification.26  ABP data on currently certified subspecialists include individuals who may not be in the workforce because of recent retirement, death, or other factors. To account for this, the following workforce descriptions are limited to the 1290 currently certified PID subspecialists aged ≤70 years. Geographic data are for the United States only. Of these, 58.8% identified as female, 41.1% as male, and 0.1% declined to answer.26  This represents a shift in the gender of the PID workforce from 66.3% male at the time of initial certification in 1994, paralleling trends in other pediatric subspecialties over the past several decades.26  The median age of PID subspecialists was 49 years; 19.8% were aged 61 to 70 years.26  Approximately 69.5% were American medical graduates (AMGs) with a Doctor of Medicine (MD) degree, 3.1% were AMGs with a Doctor of Osteopathy (DO) degree, 16.6% were international medical graduates (IMGs) with an MD degree, and 10.9% were IMGs with an international degree.26  Based on survey data from 2018 through 2022, approximately 60.0% identified as White, 17.0% as Asian, 3.3% as Middle Eastern or North African, and 17.8% as underrepresented in medicine, with 9.4% of Hispanic, Latino, or Spanish origin, 4.2% as Black or African American, and the remainder as multiracial.26 

Data on practice characteristics of the PID workforce were collected through the ABP’s Maintenance of Certification enrollment surveys from 2018 through 2022 (59.7% response rate for PID).27  The vast majority (90.9%) of PID subspecialists reported being employed full-time, with 57.5% working an average of ≥50 hours per week. Women were slightly more likely to report part-time employment than men (10.3 vs 4.5%). Only 49.2% of PID subspecialists report spending ≥50% time on clinical care compared with 77.8% of all pediatric subspecialists. Most (76.7%) PID subspecialists reported an urban primary work setting and 49% reported that more than half of their patients had public insurance.

When the workforce is limited to the United States, there are 1.7 PID subspecialists per 100 000 children aged 0 to 17 years.28  If these physicians were distributed evenly across the country, this would equate to an average of 24 PID subspecialists per state.28  However, the geographic distribution of PID subspecialists ranges from 11.1 physicians per 100 000 children in the District of Columbia to 0 PID subspecialists in Wyoming and Montana.28  Only 15 states have 2 or more PID subspecialists per 100 000 children.28  Additionally, there is wide variability in the distribution of PID subspecialists within states, with most concentrated in urban areas. Using data from 2019, the average driving distance to a PID subspecialist within the United States was 23.9 miles, ranging from 5.8 miles in Rhode Island to 320.1 miles in Montana (excluding Alaska, Hawaii, Puerto Rico, and the District of Columbia).28  After training, fellows commonly accept a first position near their training location, contributing to geographic disparities in access to PID care (Fig 1).

FIGURE 1

US distribution of pediatric infectious diseases subspecialists (aged ≤70 years) per 100 000 children (aged 0–17 years) in 2023 and fellowship program size and locations for academic year 2021–2022. Source: American Board of Pediatrics (ABP) Certification Management System and Accreditation Council for Graduate Medical Education (ACGME) program data based on the 2021–2022 academic year snapshot. Sample: Limited to pediatricians aged ≤70 years and maintaining their certification as of June 2023.

FIGURE 1

US distribution of pediatric infectious diseases subspecialists (aged ≤70 years) per 100 000 children (aged 0–17 years) in 2023 and fellowship program size and locations for academic year 2021–2022. Source: American Board of Pediatrics (ABP) Certification Management System and Accreditation Council for Graduate Medical Education (ACGME) program data based on the 2021–2022 academic year snapshot. Sample: Limited to pediatricians aged ≤70 years and maintaining their certification as of June 2023.

Close modal

According to the National Resident Matching Program, there were 59 PID fellowship programs and 84 PID first-year fellowship positions in the United States in 2022, a 22.0% increase in the number of programs and a 31.3% increase in the number of positions since 2014.29  During this same period, the proportion of programs that were not full increased from 41.7% to 59.3%, whereas the number of unfilled positions doubled from 20 (31.3%) in 2014 to 40 (47.6%) in 2022.29  Notably, there is a discrepancy between the number of applicants who match through the National Resident Matching Program and the number of fellows who start training each year, which likely reflects fellows accepting positions outside of the match and programs filling unmatched positions. A total of 62 individuals started PID fellowship in 2008 and 57 in 2022, representing an 8.1% decline.30  Although most individuals starting PID fellowship identified as female, this percentage has declined from 73.3% to 63.8% since 2008, despite rising numbers of female fellows across pediatric subspecialties. More PID fellows have DO degrees and fewer are IMGs with an international degree compared with certified PID specialists; of the 183 fellows in training levels 1 through 3 in 2022 through 2023, 97 (53.0%) were AMGs with an MD degree; 17 (9.3%) were AMGs with a DO degree; 2 (1.1%) were AMGs with an unknown degree; 32 (17.5%) were IMGs with an MD degree; 13 (7.1%) were IMGs with an international degree; and 22 (12.0%) were IMGs with an unknown degree.30 

Lifetime earning potential is associated with gaps in the pediatric subspecialist workforce and fellowship fill rates.31  Using data from national physician surveys conducted in 2018 and 2019, higher subspecialist lifetime earning potential was associated with shorter travel distances for care, a higher number of subspecialists, and higher fellowship fill rates.31  Moreover, pediatric subspecialties for which lifetime earning potential increased the least between 2007 and 2018, of which PID had the second smallest increase, and experienced less growth than subspecialties with larger increases in earning potential.31  In 2007, PID subspecialists were estimated to have a net –$1 million in lifetime earnings compared with community-based general pediatricians, a figure that had widened to a net –$1.6 million based on 2018 data.32,33  Moreover, PID subspecialists are paid on average 25% less than adult infectious diseases specialists, representing a net –$1.2 million in lifetime earnings.34 

The ABP Foundation partnered with the Carolina Health Workforce Research Center at the University of North Carolina at Chapel Hill’s Cecil G. Sheps Center for Health Services Research and Strategic Modeling and Analysis Planning Ltd. to develop an interactive, web-based model that forecasts the supply of physicians aged ≤70 years for 14 pediatric subspecialties between 2020 and 2040.35  The model contains projections at the national, Census region, and Census division levels and includes both a baseline projection and alternative projections reflecting 10 scenarios related to changes in the supply of fellows, the proportion of time in clinical care, and exit from the workforce. Workforce projections presented in the model and below are in headcount (HC; absolute numbers) and clinical workforce equivalent (CWE; HC adjusted by the reported proportion of time spent in direct clinical or consultative care, including patient billing and charting with or without trainees), per 100 000 children aged 0 to 18 years. The model also accounts for changes in the child population at the national and subnational level based on the US Census Bureau; differences by subspecialty for census regions are discussed in the summary article in this supplement.36,37  An interactive data visualization tool with projections is publicly available online.38  Numbers reported later in this article may differ from those in the previous section because of differences in years (2020 vs 2023), sample selection criteria, and inclusion of self-reported clinical time. Estimates of 95% confidence intervals for all scenarios are included in Tables 12 and the online tool; next, we focus on scenarios critical to PID.

TABLE 1

Estimated Headcount for Pediatric Infectious Diseases Subspecialists (Aged ≤70 Years) per 100 000 Children (Aged 0–18 Years) by US Census Division for Different Model Scenarios, 2020–2040a

Census RegionCensus DivisionYear 2020Year 2040
Baseline ModelBaseline Model12.5% Decrease in Fellows12.5% Increase in Fellows7% Reduction in Clinical Time7% Increase in Clinical TimeIncreased Level of Exit at All AgesIncreased Level of Exit in Mid-CareerDecrease in Fellows, Reduction in Clinical Time, and Increased Early Exit by 5 Years From the WorkforceIncrease in Fellows and an Increase in Clinical Time
Midwest East North Central 1.29
(1.28–1.31) 
1.61
(1.40–1.82) 
1.56
(1.36–1.76) 
1.67
(1.47–1.87) 
1.61
(1.40–1.82) 
1.62
(1.41–1.82) 
1.61
(1.40–1.83) 
1.63
(1.44–1.83) 
1.56
(1.35–1.76) 
1.67
(1.47–1.87) 
(+25%) (+20%) (+29%) (+25%) (+25%) (+25%) (+26%) (+21%) (+29%) 
West North Central 1.51
(1.48–1.55) 
1.66
(1.35–1.97) 
1.63
(1.38–1.88) 
1.70
(1.35–2.04) 
1.66
(1.35–1.97) 
1.66
(1.32–2.00) 
1.64
(1.33–1.94) 
1.62
(1.31–1.93) 
1.59
(1.29–1.89) 
1.70
(1.35–2.04) 
(+9%) (+8%) (+12%) (+9%) (+9%) (+8%) (+7%) (+5%) (+12%) 
South East South Central 1.35
(1.33–1.37) 
1.98
(1.60–2.36) 
1.92
(1.58–2.26) 
2.08
(1.75–2.42) 
1.98
(1.60–2.36) 
1.96
(1.63–2.30) 
2.00
(1.67–2.34) 
1.99
(1.59–2.38) 
1.91
(1.57–2.25) 
2.08
(1.75–2.42) 
(+47%) (+42%) (+54%) (+47%) (+46%) (+48%) (+47%) (+41%) (+54%) 
South Atlantic 1.83
(1.82–1.85) 
2.05
(1.90–2.20) 
1.98
(1.82–2.13) 
2.11
(1.95–2.26) 
2.05
(1.90–2.20) 
2.05
(1.91–2.20) 
2.07
(1.92–2.23) 
2.04
(1.89–2.18) 
2.00
(1.85–2.14) 
2.11
(1.95–2.26) 
(+12%) (+8%) (+15%) (+12%) (+12%) (+13%) (+11%) (+9%) (+15%) 
West South Central 1.11
(1.10–1.13) 
1.24
(1.08–1.40) 
1.19
(1.03–1.35) 
1.26
(1.10–1.42) 
1.24
(1.08–1.40) 
1.24
(1.08–1.41) 
1.23
(1.09–1.38) 
1.21
(1.07–1.35) 
1.20
(1.04–1.35) 
1.26
(1.10–1.42) 
(+12%) (+7%) (+13%) (+12%) (+12%) (+11%) (+8%) (+8%) (+13%) 
Northeast Middle Atlantic 2.02
(2.00–2.04) 
2.41
(2.16–2.67) 
2.34
(2.10–2.58) 
2.51
(2.26–2.77) 
2.41
(2.16–2.67) 
2.42
(2.15–2.68) 
2.41
(2.16–2.67) 
2.43
(2.19–2.67) 
2.37
(2.12–2.61) 
2.51
(2.26–2.77) 
(+20%) (+16%) (+25%) (+20%) (+20%) (+20%) (+20%) (+17%) (+25%) 
New England 2.78
(2.76–2.80) 
4.05
(3.50–4.61) 
3.88
(3.30–4.47) 
4.24
(3.64–4.84) 
4.05
(3.50–4.61) 
4.06
(3.52–4.61) 
4.04
(3.45–4.64) 
4.06
(3.42–4.69) 
3.85
(3.28–4.41) 
4.24
(3.64–4.84) 
(+46%) (+40%) (+53%) (+46%) (+46%) (+46%) (+46%) (+38%) (+53%) 
West Mountain 0.92
(0.90–0.95) 
1.37
(1.16–1.57) 
1.34
(1.13–1.55) 
1.43
(1.19–1.68) 
1.37
(1.16–1.57) 
1.37
(1.17–1.57) 
1.38
(1.15–1.60) 
1.38
(1.16–1.59) 
1.34
(1.11–1.56) 
1.43
(1.19–1.68) 
(+49%) (+46%) (+56%) (+49%) (+49%) (+49%) (+50%) (+45%) (+56%) 
Pacific 1.47
(1.46–1.48) 
2.15
(1.98–2.31) 
2.05
(1.87–2.23) 
2.23
(2.05–2.40) 
2.15
(1.98–2.31) 
2.14
(1.97–2.31) 
2.14
(1.97–2.31) 
2.13
(1.97–2.29) 
2.04
(1.90–2.19) 
2.23
(2.05–2.40) 
(+46%) (+40%) (+52%) (+46%) (+46%) (+46%) (+45%) (+39%) (+52%) 
Census RegionCensus DivisionYear 2020Year 2040
Baseline ModelBaseline Model12.5% Decrease in Fellows12.5% Increase in Fellows7% Reduction in Clinical Time7% Increase in Clinical TimeIncreased Level of Exit at All AgesIncreased Level of Exit in Mid-CareerDecrease in Fellows, Reduction in Clinical Time, and Increased Early Exit by 5 Years From the WorkforceIncrease in Fellows and an Increase in Clinical Time
Midwest East North Central 1.29
(1.28–1.31) 
1.61
(1.40–1.82) 
1.56
(1.36–1.76) 
1.67
(1.47–1.87) 
1.61
(1.40–1.82) 
1.62
(1.41–1.82) 
1.61
(1.40–1.83) 
1.63
(1.44–1.83) 
1.56
(1.35–1.76) 
1.67
(1.47–1.87) 
(+25%) (+20%) (+29%) (+25%) (+25%) (+25%) (+26%) (+21%) (+29%) 
West North Central 1.51
(1.48–1.55) 
1.66
(1.35–1.97) 
1.63
(1.38–1.88) 
1.70
(1.35–2.04) 
1.66
(1.35–1.97) 
1.66
(1.32–2.00) 
1.64
(1.33–1.94) 
1.62
(1.31–1.93) 
1.59
(1.29–1.89) 
1.70
(1.35–2.04) 
(+9%) (+8%) (+12%) (+9%) (+9%) (+8%) (+7%) (+5%) (+12%) 
South East South Central 1.35
(1.33–1.37) 
1.98
(1.60–2.36) 
1.92
(1.58–2.26) 
2.08
(1.75–2.42) 
1.98
(1.60–2.36) 
1.96
(1.63–2.30) 
2.00
(1.67–2.34) 
1.99
(1.59–2.38) 
1.91
(1.57–2.25) 
2.08
(1.75–2.42) 
(+47%) (+42%) (+54%) (+47%) (+46%) (+48%) (+47%) (+41%) (+54%) 
South Atlantic 1.83
(1.82–1.85) 
2.05
(1.90–2.20) 
1.98
(1.82–2.13) 
2.11
(1.95–2.26) 
2.05
(1.90–2.20) 
2.05
(1.91–2.20) 
2.07
(1.92–2.23) 
2.04
(1.89–2.18) 
2.00
(1.85–2.14) 
2.11
(1.95–2.26) 
(+12%) (+8%) (+15%) (+12%) (+12%) (+13%) (+11%) (+9%) (+15%) 
West South Central 1.11
(1.10–1.13) 
1.24
(1.08–1.40) 
1.19
(1.03–1.35) 
1.26
(1.10–1.42) 
1.24
(1.08–1.40) 
1.24
(1.08–1.41) 
1.23
(1.09–1.38) 
1.21
(1.07–1.35) 
1.20
(1.04–1.35) 
1.26
(1.10–1.42) 
(+12%) (+7%) (+13%) (+12%) (+12%) (+11%) (+8%) (+8%) (+13%) 
Northeast Middle Atlantic 2.02
(2.00–2.04) 
2.41
(2.16–2.67) 
2.34
(2.10–2.58) 
2.51
(2.26–2.77) 
2.41
(2.16–2.67) 
2.42
(2.15–2.68) 
2.41
(2.16–2.67) 
2.43
(2.19–2.67) 
2.37
(2.12–2.61) 
2.51
(2.26–2.77) 
(+20%) (+16%) (+25%) (+20%) (+20%) (+20%) (+20%) (+17%) (+25%) 
New England 2.78
(2.76–2.80) 
4.05
(3.50–4.61) 
3.88
(3.30–4.47) 
4.24
(3.64–4.84) 
4.05
(3.50–4.61) 
4.06
(3.52–4.61) 
4.04
(3.45–4.64) 
4.06
(3.42–4.69) 
3.85
(3.28–4.41) 
4.24
(3.64–4.84) 
(+46%) (+40%) (+53%) (+46%) (+46%) (+46%) (+46%) (+38%) (+53%) 
West Mountain 0.92
(0.90–0.95) 
1.37
(1.16–1.57) 
1.34
(1.13–1.55) 
1.43
(1.19–1.68) 
1.37
(1.16–1.57) 
1.37
(1.17–1.57) 
1.38
(1.15–1.60) 
1.38
(1.16–1.59) 
1.34
(1.11–1.56) 
1.43
(1.19–1.68) 
(+49%) (+46%) (+56%) (+49%) (+49%) (+49%) (+50%) (+45%) (+56%) 
Pacific 1.47
(1.46–1.48) 
2.15
(1.98–2.31) 
2.05
(1.87–2.23) 
2.23
(2.05–2.40) 
2.15
(1.98–2.31) 
2.14
(1.97–2.31) 
2.14
(1.97–2.31) 
2.13
(1.97–2.29) 
2.04
(1.90–2.19) 
2.23
(2.05–2.40) 
(+46%) (+40%) (+52%) (+46%) (+46%) (+46%) (+45%) (+39%) (+52%) 
a

numbers denote headcount per 100 000 children (95% confidence interval). Percentages indicate change from baseline year 2020.

TABLE 2

Estimated Clinical Workforce Equivalent for Pediatric Infectious Diseases Subspecialists (Aged ≤70 Years) per 100 000 Children (Aged 0–18 Years) by US Census Division for Different Model Scenarios, 2020–2040a

Census RegionCensus DivisionYear 2020Year 2040
Baseline ModelBaseline Model12.5% Decrease in Fellows12.5% Increase in Fellows7% Reduction in Clinical Time7% Increase in Clinical TimeIncreased Level of Exit at All AgesIncreased Level of Exit in Mid-CareerDecrease in Fellows, Reduction in Clinical Time, and Increased Early Exit by 5 Years From the WorkforceIncrease in Fellows and an Increase in Clinical Time
Midwest East North Central 0.58
(0.58–0.59) 
0.71
(0.62–0.81) 
0.69
(0.60–0.78) 
0.74
(0.65–0.83) 
0.66
(0.58–0.75) 
0.76
(0.67–0.86) 
0.71
(0.62–0.81) 
0.72
(0.64–0.81) 
0.64
(0.56–0.73) 
0.79
(0.69–0.89) 
(+22%) (+18%) (+26%) (+13%) (+31%) (+22%) (+24%) (+10%) (+35%) 
West North Central 0.68
(0.67–0.69) 
0.73
(0.59–0.86) 
0.71
(0.60–0.82) 
0.75
(0.59–0.90) 
0.68
(0.55–0.80) 
0.78
(0.61–0.94) 
0.72
(0.58–0.85) 
0.71
(0.57–0.85) 
0.65
(0.53–0.77) 
0.80
(0.63–0.96) 
(+7%) (+5%) (+10%) (–1%) (+14%) (+5%) (+5%) (–5%) (+17%) 
South East South Central 0.61
(0.60–0.61) 
0.87
(0.70–1.04) 
0.84
(0.70–0.99) 
0.92
(0.77–1.07) 
0.81
(0.65–0.97) 
0.93
(0.77–1.08) 
0.88
(0.74–1.03) 
0.88
(0.70–1.05) 
0.78
(0.65–0.92) 
0.98
(0.82–1.14) 
(+44%) (+39%) (+52%) (+34%) (+53%) (+46%) (+45%) (+29%) (+62%) 
South Atlantic 0.81
(0.81–0.82) 
0.90
(0.84–0.97) 
0.87
(0.80–0.94) 
0.93
(0.86–0.99) 
0.84
(0.78–0.90) 
0.97
(0.90–1.04) 
0.91
(0.84–0.98) 
0.90
(0.84–0.96) 
0.82
(0.76–0.88) 
0.99
(0.92–1.06) 
(+11%) (+7%) (+14%) (+3%) (+19%) (+12%) (+10%) (0%) (+22%) 
West South Central 0.50
(0.50–0.51) 
0.55
(0.48–0.62) 
0.52
(0.45–0.60) 
0.56
(0.48–0.63) 
0.51
(0.45–0.58) 
0.59
(0.51–0.67) 
0.54
(0.48–0.61) 
0.53
(0.47–0.59) 
0.49
(0.43–0.55) 
0.59
(0.52–0.67) 
(+9%) (+4%) (+11%) (+2%) (+17%) (+8%) (+6%) (–2%) (+18%) 
Northeast Middle Atlantic 0.90
(0.89–0.91) 
1.06
(0.95–1.17) 
1.03
(0.92–1.14) 
1.10
(0.99–1.22) 
0.99
(0.88–1.09) 
1.14
(1.01–1.26) 
1.06
(0.95–1.17) 
1.07
(0.96–1.18) 
0.97
(0.87–1.07) 
1.18
(1.06–1.30) 
(+18%) (+15%) (+23%) (+10%) (+27%) (+18%) (+19%) (+8%) (+32%) 
New England 1.24
(1.23–1.25) 
1.78
(1.54–2.03) 
1.71
(1.45–1.96) 
1.87
(1.60–2.14) 
1.66
(1.43–1.89) 
1.91
(1.66–2.16) 
1.78
(1.53–2.04) 
1.79
(1.51–2.06) 
1.57
(1.34–1.80) 
2.00
(1.72–2.29) 
(+44%) (+38%) (+51%) (+34%) (+55%) (+44%) (+45%) (+27%) (+62%) 
West Mountain 0.41
(0.40–0.42) 
0.61
(0.52–0.70) 
0.59
(0.50–0.69) 
0.64
(0.53–0.75) 
0.57
(0.48–0.65) 
0.65
(0.55–0.75) 
0.61
(0.51–0.71) 
0.61
(0.52–0.71) 
0.55
(0.46–0.64) 
0.68
(0.56–0.80) 
(+48%) (+44%) (+55%) (+37%) (+58%) (+48%) (+48%) (+34%) (+66%) 
Pacific 0.65
(0.65–0.66) 
0.95
(0.87–1.02) 
0.90
(0.82–0.98) 
0.99
(0.91–1.06) 
0.88
(0.81–0.95) 
1.01
(0.93–1.09) 
0.95
(0.87–1.02) 
0.94
(0.87–1.01) 
0.84
(0.78–0.90) 
1.05
(0.97–1.14) 
(+45%) (+38%) (+51%) (+35%) (+55%) (+45%) (+44%) (+28%) (+61%) 
Census RegionCensus DivisionYear 2020Year 2040
Baseline ModelBaseline Model12.5% Decrease in Fellows12.5% Increase in Fellows7% Reduction in Clinical Time7% Increase in Clinical TimeIncreased Level of Exit at All AgesIncreased Level of Exit in Mid-CareerDecrease in Fellows, Reduction in Clinical Time, and Increased Early Exit by 5 Years From the WorkforceIncrease in Fellows and an Increase in Clinical Time
Midwest East North Central 0.58
(0.58–0.59) 
0.71
(0.62–0.81) 
0.69
(0.60–0.78) 
0.74
(0.65–0.83) 
0.66
(0.58–0.75) 
0.76
(0.67–0.86) 
0.71
(0.62–0.81) 
0.72
(0.64–0.81) 
0.64
(0.56–0.73) 
0.79
(0.69–0.89) 
(+22%) (+18%) (+26%) (+13%) (+31%) (+22%) (+24%) (+10%) (+35%) 
West North Central 0.68
(0.67–0.69) 
0.73
(0.59–0.86) 
0.71
(0.60–0.82) 
0.75
(0.59–0.90) 
0.68
(0.55–0.80) 
0.78
(0.61–0.94) 
0.72
(0.58–0.85) 
0.71
(0.57–0.85) 
0.65
(0.53–0.77) 
0.80
(0.63–0.96) 
(+7%) (+5%) (+10%) (–1%) (+14%) (+5%) (+5%) (–5%) (+17%) 
South East South Central 0.61
(0.60–0.61) 
0.87
(0.70–1.04) 
0.84
(0.70–0.99) 
0.92
(0.77–1.07) 
0.81
(0.65–0.97) 
0.93
(0.77–1.08) 
0.88
(0.74–1.03) 
0.88
(0.70–1.05) 
0.78
(0.65–0.92) 
0.98
(0.82–1.14) 
(+44%) (+39%) (+52%) (+34%) (+53%) (+46%) (+45%) (+29%) (+62%) 
South Atlantic 0.81
(0.81–0.82) 
0.90
(0.84–0.97) 
0.87
(0.80–0.94) 
0.93
(0.86–0.99) 
0.84
(0.78–0.90) 
0.97
(0.90–1.04) 
0.91
(0.84–0.98) 
0.90
(0.84–0.96) 
0.82
(0.76–0.88) 
0.99
(0.92–1.06) 
(+11%) (+7%) (+14%) (+3%) (+19%) (+12%) (+10%) (0%) (+22%) 
West South Central 0.50
(0.50–0.51) 
0.55
(0.48–0.62) 
0.52
(0.45–0.60) 
0.56
(0.48–0.63) 
0.51
(0.45–0.58) 
0.59
(0.51–0.67) 
0.54
(0.48–0.61) 
0.53
(0.47–0.59) 
0.49
(0.43–0.55) 
0.59
(0.52–0.67) 
(+9%) (+4%) (+11%) (+2%) (+17%) (+8%) (+6%) (–2%) (+18%) 
Northeast Middle Atlantic 0.90
(0.89–0.91) 
1.06
(0.95–1.17) 
1.03
(0.92–1.14) 
1.10
(0.99–1.22) 
0.99
(0.88–1.09) 
1.14
(1.01–1.26) 
1.06
(0.95–1.17) 
1.07
(0.96–1.18) 
0.97
(0.87–1.07) 
1.18
(1.06–1.30) 
(+18%) (+15%) (+23%) (+10%) (+27%) (+18%) (+19%) (+8%) (+32%) 
New England 1.24
(1.23–1.25) 
1.78
(1.54–2.03) 
1.71
(1.45–1.96) 
1.87
(1.60–2.14) 
1.66
(1.43–1.89) 
1.91
(1.66–2.16) 
1.78
(1.53–2.04) 
1.79
(1.51–2.06) 
1.57
(1.34–1.80) 
2.00
(1.72–2.29) 
(+44%) (+38%) (+51%) (+34%) (+55%) (+44%) (+45%) (+27%) (+62%) 
West Mountain 0.41
(0.40–0.42) 
0.61
(0.52–0.70) 
0.59
(0.50–0.69) 
0.64
(0.53–0.75) 
0.57
(0.48–0.65) 
0.65
(0.55–0.75) 
0.61
(0.51–0.71) 
0.61
(0.52–0.71) 
0.55
(0.46–0.64) 
0.68
(0.56–0.80) 
(+48%) (+44%) (+55%) (+37%) (+58%) (+48%) (+48%) (+34%) (+66%) 
Pacific 0.65
(0.65–0.66) 
0.95
(0.87–1.02) 
0.90
(0.82–0.98) 
0.99
(0.91–1.06) 
0.88
(0.81–0.95) 
1.01
(0.93–1.09) 
0.95
(0.87–1.02) 
0.94
(0.87–1.01) 
0.84
(0.78–0.90) 
1.05
(0.97–1.14) 
(+45%) (+38%) (+51%) (+35%) (+55%) (+45%) (+44%) (+28%) (+61%) 
a

numbers denote clinical workforce equivalent per 100 000 children (95% confidence interval). Percentages indicate change from baseline year 2020.

Between 2020 and 2040, HC is projected to increase by 41%, with a slightly smaller projected increase in CWE. By comparison, the overall pediatric subspecialty workforce HC is projected to increase by 69%, with an accompanying increase in CWE of 68%. Of the 14 subspecialties, PID is projected to have the fourth smallest growth in HC and the third smallest increase in CWE. Moreover, adjusting for anticipated growth in the pediatric population between 2020 and 2040, the HC per 100 000 children is projected to increase by only 25%, with a corresponding increase in CWE per 100 000 children (+23%).38,39 

Disparities in the geographic distribution of PID subspecialists are projected to worsen between 2020 and 2040 (Tables 12, Fig 2). In general, census regions with a lower density of PID subspecialists in 2020 will have smaller improvements in access to PID subspecialists over the subsequent 2 decades. In 2020, the model estimates that the Northeast Census region has 63% and 47% more PID subspecialists per 100 000 children than the Midwest and South regions. Moreover, the Northeast region is projected to experience 28% growth in the number of PID subspecialists between 2020 and 2040, whereas growth in the Midwest and South is expected to be slower (Midwest, mean: 19%; South, mean: 15%). This is particularly concerning for the South Census region, which has the highest poverty rate, the lowest insurance coverage rate, and some of the worst child health outcomes of any census region.40  In contrast, although the number of PID subspecialists in the West region is lower than in other Census regions (1.29 per 100 000 children in 2020), this number is projected to grow by 46% between 2020 and 2040. Despite this growth, substantial disparities in access to PID care are projected to persist in the West at the Census division level. The Mountain division had the lowest number of PID subspecialists of any Census division in 2020 (0.92 per 100 000 children), including 37% fewer PID subspecialists than the neighboring Pacific division. Between 2020 and 2040, the number of PID subspecialists in the Mountain and Pacific divisions is predicted to grow at comparable rates (+49% and +46%, respectively), with the Mountain division projected to remain the census division with the fewest PID subspecialists in 2040.

FIGURE 2

Estimated clinical workforce equivalent for pediatric infectious diseases subspecialists (aged ≤70 years) per 100 000 children (aged 0–18 years) by US Census region, 2020–2040. Clinical workforce equivalent indicates headcount adjusted by the reported proportion of time spent in direct clinical or consultative care.

FIGURE 2

Estimated clinical workforce equivalent for pediatric infectious diseases subspecialists (aged ≤70 years) per 100 000 children (aged 0–18 years) by US Census region, 2020–2040. Clinical workforce equivalent indicates headcount adjusted by the reported proportion of time spent in direct clinical or consultative care.

Close modal

Although the baseline model estimates the projected supply of PID subspecialists based on historical data, the alternative projections provide information on the supply of PID subspecialists should future trends deviate from data that informed the baseline model. Factors projected to have the largest impact on the PID workforce between 2020 and 2040 include changes in the number of trainees entering fellowship and the percentage of time devoted to direct clinical care (Tables 12). For instance, a 12.5% reduction in the number of PID fellows by 2030 would reduce projected growth in HC between 2020 and 2040 from 25% to 20%, with a corresponding reduction in growth of CWE from 23% to 18%. Similarly, a 7% decrease in the proportion of time devoted to clinical care by PID subspecialists would reduce projected population-adjusted growth in CWE from 23% to 18%. Alternative scenarios modeling an increase in attrition from the workforce are projected to have a comparatively small impact on the PID workforce. For instance, if all PID subspecialists exited the workforce 5 years earlier over a 3-year period (2021–2023) compared with baseline (2019), this would have a minimal effect on the number of PID subspecialists in 2040 and would only decrease CWE by 8%. Notably, the cooccurrence of alternative scenarios results in approximately additive effects, with a worst-case scenario that combines the assumptions of the 3 aforementioned alternative scenarios reducing projected growth of the population-adjusted number of PID subspecialists from 25% to 20% and CWE from 23% to 10%. Moreover, the impact of these alternative scenarios is anticipated to be most significant in census divisions that currently have fewer PID subspecialists and are projected to have relatively little growth in the PID workforce. For instance, in the West South Central Census division, which had the second lowest number of CWE in 2020, the worst-case scenario is projected to result in a 2% reduction in CWE per 100 000 children between 2020 and 2040 compared with a 9% increase projected by the baseline model. Thus, there is the threat that current disparities in access to PID care across census divisions could worsen with deviations from the baseline model.

There are several reasons to anticipate that PID workforce growth may differ from these projections. First, the model held constant the annual number of fellows starting PID fellowship at 60 fellows per year based on 2019 data. In the past decade, there have been several years with fewer than 60 trainees starting fellowships, and there has been a general downward trend in the numbers starting PID fellowships since 2008.30  As such, the alternative scenario that decreases the incoming fellows by 12.5% may approximate the current reality.

Similarly, estimates of attrition from the PID workforce are based on data collected before the COVID-19 pandemic. The pandemic has been associated with heavy work demands for PID subspecialists, typically without additional compensation, and often hostile public portrayals of and dialogue with those working to inform policy focused on containment and mitigation measures.4144  Trainees may be less attracted to PID after witnessing this increased workload and considering the challenges that PID physicians face regarding vaccine hesitancy and the implementation of infection control measures. With the virus that causes COVID-19 becoming endemic and the ongoing threat of other emerging infectious diseases, attrition from clinical PID positions or reductions in clinical hours worked by PID subspecialists could exceed what was considered in alternative model scenarios without further efforts to mitigate the increased demands placed on PID subspecialists. As such, the early exit, CWE decrease, and worst-case scenarios may more accurately represent future changes in the PID workforce.

Finally, because this modeling analysis used self-reported survey data to calculate CWE, the extent to which reported clinical effort includes non–patient-facing clinical activities such as antimicrobial stewardship and infection prevention and control is unknown. Clinical time may remain low or decrease if PID subspecialists are concentrated in academic medical centers, where nonclinical activities such as research may be valued more than in other settings. Because direct clinical revenue generated by PID subspecialists is generally lower than other pediatric subspecialties, health systems may be reluctant to provide additional salary support for clinical care, driving PID physicians to pursue other activities such as research and administrative or education roles. If PID fellowship positions and programs continue to go unfilled, consolidation of training into fewer locations could worsen geographical disparities. Next, we provide some potential implications for the PID subspecialty workforce.

School-based programs introducing children and adolescents to PID enable exploration of pediatrics before medical school, when most education is focused on the care of adults and as little as 4 weeks may be devoted to pediatrics. Nearly three-quarters of medical students graduate in debt, with a median medical school debt of $200 000 in 2019.45  Educational debt may play a role in subspecialty choice, and disparities in debt by socioeconomic status, race, and ethnicity could limit efforts to increase PID workforce diversity.4547  Since becoming a recognized pediatric subspecialty, PID fellowship has required a minimum of 3 years of training. In recent years, there has been increased interest in shortening this training to 2 years, in part because of increasing numbers of PID fellows pursuing positions focused on antimicrobial stewardship, quality improvement, and hospital epidemiology, with an accompanying decrease in fellows pursuing basic science research careers. Notably, internal medicine has successfully maintained 2-year fellowship programs for decades; the initial board pass rate for adult infectious diseases was 92% in 2021.48  Shortening the required duration of PID fellowship training could lessen the financial burden assumed by trainees and stimulate interest in PID among the next generation of pediatricians. Furthermore, additional flexibility could be built into training programs to support the varied interests of individuals pursuing a career in PID. Creating pathways for sub-subspecialty training in disciplines such as transplant and immunocompromised host infectious diseases, antimicrobial stewardship, and infection prevention would enable interested fellows to complete an additional year of training in these disciplines during a 3-year training program.

Improving children’s access to PID care may require changes to how PID subspecialists provide patient care and alternative staffing for roles traditionally occupied by PID subspecialists. PID subspecialists could increase the proportion of time they devote to clinical care, although without other changes in care delivery, this would leave less time for other critical activities (eg, research, infection prevention). Increasing the use of advanced practice providers and shifting nonclinical work currently performed by PID subspecialists to other health professionals (eg, antimicrobial stewardship pharmacists) could increase the time that PID subspecialists spend in clinical care, though some of these providers also face workforce challenges.49  Additionally, general pediatricians could be trained to provide care for some infections that are currently comanaged with PID subspecialists through an increased emphasis on infectious diseases in pediatric residency or through short courses focused on specific PID competencies, such as has been done to train physicians in HIV care.50,51  Consideration should be given to increasing the involvement of general pediatricians in public health efforts focused on preventing infections among children in the community. Finally, the expansion of telemedicine is a promising solution to reducing current geographic disparities in access to PID care. Previous studies reported that pediatric subspecialty care delivered via telemedicine was associated with high parental satisfaction and, in some cases, improved health outcomes.5255  Recently, a step-by-step guide was proposed for the provision of remote infectious diseases support for patient consultations and antimicrobial stewardship activities in underserved communities in the United States.56 

The physician compensation structure in the United States is complex and related in part to the value that insurers place on the performance of procedures rather than investigation through history and physical examination. With the exception of 3 procedure-intensive pediatric subspecialties (cardiology, critical care medicine, and neonatal-perinatal medicine), pediatric subspecialists are compensated less than their general pediatric colleagues and their internal medicine subspecialty counterparts.33,34  Leadership in several pediatric departments have recently taken steps to improve equity of subspecialist compensation by adjusting the salaries of individuals in low-paying pediatric subspecialties (including PID) to be commensurate with those of pediatric hospital medicine subspecialists or their internal medicine subspecialist counterparts. Differences in insurance coverage of children and adults also contribute to the disparity in compensation among pediatric and internal medicine subspecialists. A significant and increasing percentage of children (>50% as of November 2022) are insured through Medicaid or the Children’s Health Insurance Program, with Medicaid reimbursement remaining well below that of Medicare and private insurance.57,58  Working with legislators to reform Medicaid and move beyond fee-for-service models is necessary to remedy these inequalities in physician compensation, stimulate growth of the pediatric subspecialty workforce, and demonstrate the value of children in our society.59 

To anticipate and effectively respond to changes in the future PID workforce, research priorities include evaluating the impact of changes in clinical practice on access to and delivery of PID care, understanding factors that contribute to shifting demographics in the PID workforce, and determining the effects of emerging infections on PID subspecialist supply. Although telemedicine has the potential to substantially expand access to PID subspecialty care, few previous studies compared in-person and telemedicine-based PID care. Notably, a recent study conducted at 3 community hospitals found that a shift from in-person to telemedicine-based infectious diseases consultation was associated with more consultations, although length of hospital stay and mortality were unchanged.60  Additionally, future studies could investigate the use of telemedicine to expand pediatric antimicrobial stewardship and infection prevention initiatives to rural US areas. Relatively little is also known about how the COVID-19 pandemic may influence the decisions of pediatric residents pursuing fellowship training or PID subspecialists exiting the workforce. More than one-quarter of the current PID workforce are IMGs, yet specific data are lacking on practice locations of IMGs after PID fellowship and how many of these individuals leave the US PID workforce to pursue positions abroad. Finally, a better understanding of factors contributing to the declining proportion of PID fellows who identify as female is needed and learning how PID can offer desirable career pathways to all pediatric trainees.

Although the PID workforce is anticipated to grow between 2020 and 2040, growth is lower than that of other subspecialties; it is uncertain if this growth is realistic and will be sufficient to meet anticipated or unexpected growth in the need for PID care. In particular, increasing populations of immunocompromised or medically complex children, rising antimicrobial resistance, and emerging pathogens in an increasingly connected world threaten to strain the PID workforce over the coming decades. Additionally, the availability of PID care is projected to remain concentrated in urban areas, with geographic disparities in access worsening between 2020 and 2040. A multifaceted approach will be necessary to ensure that the PID subspecialty thrives over the next several decades and is able to meet the needs of children.

The authors thank Emily McCartha, Andrew Knapton, and Adriana R. Gaona for their review of the modeling data presented. They also thank Virginia A. Moyer and Patience Leino for their editorial support. Last, they thank the pediatricians who shared their information with the American Board of Pediatrics Foundation and made this supplement possible.

Drs Cataldi, Kelly, Myers, Schlaudecker, and Shah drafted the initial manuscript and reviewed and revised the manuscript; Dr Vinci reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FUNDING: This supplement was funded by the American Board of Pediatrics Foundation. Dr Kelly was supported by a National Institutes of Health Career Development Award (K23-AI135090).

CONFLICT OF INTEREST DISCLOSURES: Dr Vinci is on the Board of Directors of the American Board of Pediatrics and Dr Myers is a member of the Pediatric Infectious Diseases Subboard. The other authors have indicated they have no potential conflicts of interest to disclose. The American Board of Pediatrics Foundation, the Carolina Health Workforce Research Center at the University of North Carolina at Chapel Hill’s Cecil G. Sheps Center for Health Services Research, and the Strategic Modelling and Analysis Ltd. partnered in the design and conduct of this study. The content is solely the authors’ responsibility and does not necessarily represent the official views of the American Board of Pediatrics or the American Board of Pediatrics Foundation.

ABP

American Board of Pediatrics

AMG

American medical graduate

CWE

Clinical workforce equivalent

DO

Doctor of Osteopathy

HC

Headcount

IMG

International medical graduate

MD

Doctor of Medicine

PID

Pediatric infectious diseases

1
Leslie
LK
,
Orr
CJ
,
Turner
AL
, et al
.
Child health and the United States pediatric subspecialty workforce: planning for the future
.
Pediatrics
.
2024
;
153
(
suppl 2
):
e2023063678B
2
Goto
T
,
Tsugawa
Y
,
Mansbach
JM
,
Camargo
CA
Jr
,
Hasegawa
K
.
Trends in infectious disease hospitalizations in US children, 2000 to 2012
.
Pediatr Infect Dis J
.
2016
;
35
(
6
):
e158
e163
3
Witt
WP
,
Weiss
AJ
,
Elixhauser
A
.
Overview of hospital stays for children in the United States, 2012
. Available at: https://hcup-us.ahrq.gov/reports/statbriefs/sb180-Hospitalizations-United-States-2012.pdf. Accessed November 29, 2023
4
Leyenaar
JK
,
Ralston
SL
,
Shieh
MS
,
Pekow
PS
,
Mangione-Smith
R
,
Lindenauer
PK
.
Epidemiology of pediatric hospitalizations at general hospitals and freestanding children’s hospitals in the United States
.
J Hosp Med
.
2016
;
11
(
11
):
743
749
5
Keren
R
,
Luan
X
,
Localio
R
, et al
;
Pediatric Research in Inpatient Settings (PRIS) Network
.
Prioritization of comparative effectiveness research topics in hospital pediatrics
.
Arch Pediatr Adolesc Med
.
2012
;
166
(
12
):
1155
1164
6
Gerber
JS
,
Newland
JG
,
Coffin
SE
, et al
.
Variability in antibiotic use at children’s hospitals
.
Pediatrics
.
2010
;
126
(
6
):
1067
1073
7
Pollack
LA
,
Srinivasan
A
.
Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention
.
Clin Infect Dis
.
2014
;
59
(
suppl 3
):
S97
100
.
8
Nathwani
D
,
Varghese
D
,
Stephens
J
,
Ansari
W
,
Martin
S
,
Charbonneau
C
.
Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review
.
Antimicrob Resist Infect Control
.
2019
;
8
:
35
9
Myers
AL
,
Fussell
JJ
,
Moffatt
ME
, et al
.
The importance of subspecialty pediatricians to the health and wellbeing of the nation’s children
.
J Pediatr
.
2023
;
257
:
113365
10
Messacar
K
,
Hurst
AL
,
Child
J
, et al
.
Clinical impact and provider acceptability of real-time antimicrobial stewardship decision support for rapid diagnostics in children with positive blood culture results
.
J Pediatric Infect Dis Soc
.
2017
;
6
(
3
):
267
274
11
Messacar
K
,
Parker
SK
,
Todd
JK
,
Dominguez
SR
.
Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship
.
J Clin Microbiol
.
2017
;
55
(
3
):
715
723
12
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States
.
Combating antimicrobial resistance and protecting the miracle of modern medicine
. Available at: https://www.ncbi.nlm.nih.gov/books/NBK574712/. Accessed November 29, 2023
13
Baker
RE
,
Mahmud
AS
,
Miller
IF
, et al
.
Infectious disease in an era of global change
.
Nat Rev Microbiol
.
2022
;
20
(
4
):
193
205
14
Carlson
CJ
,
Albery
GF
,
Merow
C
, et al
.
Climate change increases cross-species viral transmission risk
.
Nature
.
2022
;
607
(
7919
):
555
562
15
Mahmud
AS
,
Martinez
PP
,
He
J
,
Baker
RE
.
The impact of climate change on vaccine-preventable diseases: insights from current research and new directions
.
Curr Environ Health Rep
.
2020
;
7
(
4
):
384
391
16
Burton
DR
,
Topol
EJ
.
Variant-proof vaccines - invest now for the next pandemic
.
Nature
.
2021
;
590
(
7846
):
386
388
17
Ruperto
N
,
Lovell
DJ
,
Cuttica
R
, et al
;
Paediatric Rheumatology International Trials Organisation
;
Pediatric Rheumatology Collaborative Study Group
.
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
.
Arthritis Rheum
.
2007
;
56
(
9
):
3096
3106
18
Holmer
A
,
Singh
S
.
Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases
.
Expert Rev Clin Immunol
.
2019
;
15
(
9
):
969
979
19
Organ Procurement and Transplantation Network
.
National data, 2020
. Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data. Accessed October 26, 2022
20
Auletta
JJ
,
Kou
J
,
Chen
M
,
Shaw
BE
.
Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2021
. Available at: https://cibmtr.org/CIBMTR/Resources/Summary-Slides-Reports. Accessed March 12, 2023
21
Symeonidis
N
,
Jakubowski
A
,
Pierre-Louis
S
, et al
.
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir
.
Transpl Infect Dis
.
2007
;
9
(
2
):
108
113
22
Spees
LP
,
Martin
PL
,
Kurtzberg
J
, et al
.
Reduction in mortality after umbilical cord blood transplantation in children over a 20-year period (1995-2014)
.
Biol Blood Marrow Transplant
.
2019
;
25
(
4
):
756
763
23
Singh
S
,
Facciorusso
A
,
Dulai
PS
,
Jairath
V
,
Sandborn
WJ
.
Comparative risk of serious infections with biologic and/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis
.
Clin Gastroenterol Hepatol
.
2020
;
18
(
1
):
69
81.e3
24
Pelland-Marcotte
M-C
,
Hwee
J
,
Pole
JD
,
Nathan
PC
,
Sung
L
.
Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature
.
Leuk Lymphoma
.
2019
;
60
(
9
):
2104
2114
25
Shulman
ST
.
The history of pediatric infectious diseases
.
Pediatr Res
.
2004
;
55
(
1
):
163
176
26
The American Board of Pediatrics
.
Pediatric subspecialists ever certified
. Available at: https://www.abp.org/dashboards/pediatric-subspecialists-ever-certified. Accessed June 22, 2023
27
The American Board of Pediatrics
.
Results: continuing certification (MOC) enrollment surveys for 2018 to 2020
. Available at: https://www.abp.org/content/results-continuing-certification-moc-enrollment-surveys-2018-2020. Accessed June 22, 2023
28
The American Board of Pediatrics
.
Pediatric subspecialty U.S. state and county maps
. Available at: https://www.abp.org/dashboards/pediatric-subspecialty-us-state-and-county-maps. Accessed June 22, 2023
29
The American Board of Pediatrics
.
Comparison of ABP data to the NRMP match data
. Available at: https://www.abp.org/content/comparison-abp-data-nrmp-match-data. Accessed June 22, 2023
30
The American Board of Pediatrics
.
Yearly growth in pediatric fellows by subspecialty by demographics and program characteristics
. Available at: https://www.abp.org/content/yearly-growth-pediatric-fellows-subspecialty-demographics-and-program-characteristics. Accessed June 22, 2023
31
Catenaccio
E
,
Rochlin
JM
,
Simon
HK
.
Association of lifetime earning potential and workforce distribution among pediatric subspecialists
.
JAMA Pediatr
.
2021
;
175
(
10
):
1053
1059
32
Rochlin
JM
,
Simon
HK
.
Does fellowship pay: what is the long-term financial impact of subspecialty training in pediatrics?
Pediatrics
.
2011
;
127
(
2
):
254
260
33
Catenaccio
E
,
Rochlin
JM
,
Simon
HK
.
Differences in lifetime earning potential for pediatric subspecialists
.
Pediatrics
.
2021
;
147
(
4
)
e2020027771
34
Catenaccio
E
,
Rochlin
JM
,
Simon
HK
.
Differences in lifetime earning potential between pediatric and adult physicians
.
Pediatrics
.
2021
;
148
(
2
):
e2021051194
35
Fraher
E
,
Knapton
A
,
McCartha
E
,
Leslie
LK
.
Forecasting the future supply of pediatric subspecialists in the United States: 2020–2040
.
Pediatrics
.
36
Orr
CJ
,
McCartha
E
,
Vinci
R
, et al
.
Projecting the future pediatric subspecialty workforce: summary and recommendations
.
Pediatrics
.
37
University of Virginia Weldon Cooper Center, Demographics Research Group
.
National population projections, 2018
. Available at: https://demographics.coopercenter.org/national-population-projections. Accessed July 17, 2023
38
The Program on Health Workforce Research and Policy at the Cecil G Sheps Center, University of North Carolina at Chapel Hill and the American Board of Pediatrics Foundation
.
Projecting the future of the United States pediatric subspecialty workforce: a workforce microsimulation model, 2020-2040
. Available at: https://abpv2-dept-healthworkforce.apps.cloudapps.unc.edu/. Accessed July 17, 2023
39
Vespa
J
,
Armstrong
DM
,
Medina
L
.
Demographic turning points for the United States: population projections for 2020 to 2060
. Available at: https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144.pdf. Accessed July 17, 2023
40
Artiga
S
,
Damico
A
.
Health and health coverage in the South: a data update
. Available at: https://www.kff.org/racial-equity-and-health-policy/issue-brief/health-and-health-coverage-in-the-south-a-data-update/. Accessed January 3, 2023
41
Nori
P
,
Stevens
MP
,
Patel
PK
.
Rising from the pandemic ashes: reflections on burnout and resiliency from the infection prevention and antimicrobial stewardship workforce
.
Antimicrob Steward Healthc Epidemiol
.
2022
;
2
(
1
):
e101
42
Scherer
EM
,
Backer
M
,
Carvajal
K
, et al
;
Infectious Diseases Clinical Research Consortium (IDCRC) Mentorship Program Writing Group
.
The COVID-19 pandemic unmasked the challenges faced by early-stage faculty in infectious diseases: a call to action
.
Clin Infect Dis
.
2023
;
76
(
4
):
753
759
43
Ward
JA
,
Stone
EM
,
Mui
P
,
Resnick
B
.
Pandemic-related workplace violence and its impact on public health officials, March 2020 – January 2021
.
Am J Public Health
.
2022
;
112
(
5
):
736
746
44
Mello
MM
,
Greene
JA
,
Sharfstein
JM
.
Attacks on public health officials during COVID-19
.
JAMA
.
2020
;
324
(
8
):
741
742
45
Association of American Medical Colleges
.
Physician education debt and the cost to attend medical school
. Available at: https://store.aamc.org/downloadable/download/sample/sample_id/368/. Accessed January 3, 2023.
46
Orr
CJ
,
Turner
AL
,
Ritter
VS
,
Gutierrez-Wu
J
,
Leslie
LK
.
Pursuing a career in pediatrics: Intersection of educational debt and race/ethnicity
.
J Pediatr
.
2023
;
252
:
162
170
47
Haftel
HM
,
Somberg
CM
,
Frintner
MPM
.
Factors that are priorities in pediatric subspecialty choice
.
Acad Pediatr
.
2020
;
20
(
7
):
e38
e39
48
American Board of Internal Medicine
.
Initial certification pass rates
. Available at: https://www.abim.org/Media/yeqiumdc/certification-pass-rates.pdf. Accessed January 3, 2023
49
Timbrook
TT
,
Prinzi
AM
,
Spivak
ES
.
Diagnostic and antimicrobial stewardship workforce challenges: a crisis in combating antimicrobial resistance
.
Antimicrob Steward Healthc Epidemiol
.
2023
;
3
(
1
):
e60
50
Carrascal
AF
,
Montesano-Ostrander
K
,
Rukeyser
J
,
Agins
BD
.
Training HIV clinicians and building a clinical workforce: the experience in New York State
.
AIDS Public Policy J
.
2005
;
20
(
3-4
):
102
107
51
Boehler
M
,
Schechtman
B
,
Rivero
R
, et al
.
Developing the HIV workforce: the MATEC clinician scholars program
.
J Assoc Nurses AIDS Care
.
2016
;
27
(
3
):
246
260
52
Marcin
JP
,
Ellis
J
,
Mawis
R
,
Nagrampa
E
,
Nesbitt
TS
,
Dimand
RJ
.
Using telemedicine to provide pediatric subspecialty care to children with special health care needs in an underserved rural community
.
Pediatrics
.
2004
;
113
(
1 Pt 1
):
1
6
53
Hooshmand
M
,
Foronda
C
.
Comparison of telemedicine to traditional face-to-face care for children with special needs: a quasiexperimental study
.
Telemed J E Health
.
2018
;
24
(
6
):
433
441
54
Dayal
P
,
Chang
CH
,
Benko
WS
, et al
.
Hospital utilization among rural children served by pediatric neurology telemedicine clinics
.
JAMA Netw Open
.
2019
;
2
(
8
):
e199364
55
Stuckey
R
,
Domingues-Montanari
S
.
Telemedicine is helping the parents of children with neurodevelopmental disorders living in remote and deprived areas
.
Paediatr Int Child Health
.
2017
;
37
(
3
):
155
157
56
Livorsi
DJ
,
Abdel-Massih
R
,
Crnich
CJ
, et al
.
An implementation roadmap for establishing remote infectious disease specialist support for consultation and antibiotic stewardship in resource-limited settings
.
Open Forum Infect Dis
.
2022
;
9
(
12
):
ofac588
57
Centers for Medicare and Medicaid Services
.
November 2022 Medicaid and CHIP enrollment trends snapshot
. Available at: https://www.medicaid.gov/medicaid/national-medicaid-chipprogram-information/downloads/november-2022-medicaid-chip-enrollment-trend-snapshot.pdf. Accessed July 18, 2023
58
Zuckerman
S
,
Skopec
L
,
Aarons
J
.
Medicaid physician fees remained substantially below fees paid by Medicare in 2019
.
Health Aff (Millwood)
.
2021
;
40
(
2
):
343
348
59
Swartz
TH
,
Aberg
JA
.
Preserving the future of infectious diseases: why we must address the decline in compensation for clinicians and researchers
.
Clin Inf Dis
.
2023
;
77
(
10
):
1387
1394
60
Gupta
N
,
Bariola
JR
,
Mellors
JW
,
Abdel-Massih
RC
.
In-person versus tele-infectious disease (Tele-ID) care: is one better?
Open Forum Infect Dis
.
2022
;
9
(
8
):
ofac410